Pamela Wallin, Canadian consul general in New York City, will speak on the topic "The Media and Diplomacy: Influencing Public Perceptions of Canada-U.S. Relations" on the Cornell campus Thursday, Jan. 23.
The Cornell Board of Trustees will hold its first meetings of 2003 at the Weill Medical College of Cornell University in New York City, Jan. 23 through 25.
Following Super Bowl Sunday this Jan. 26, Douglas Stayman and his marketing students at Cornell University's Johnson Graduate School of Management will huddle to discuss what's behind the game plans of this year's biggest advertisers.
If you are looking for a thoughtful, balanced publication that answers fundamental questions about why genetically engineered food crops are developed, whether they are safe for humans and the environment, and how they affect the global food system, read "Agricultural Biotechnology: Informing the Dialogue,
Two firefighters from the Fire Department of New York (FDNY) will give six presentations in the Ithaca area Thursday and Friday, Jan. 16 and 17, as part of a statewide tour to give thanks to communities who supported rescue efforts in the aftermath of the terrorist attacks on the World Trade Center on Sept. 11, 2001. The program will include video and artifacts from Ground Zero. (January 14, 2003)
Hundreds of thousands of young children are interviewed as eyewitnesses every year in the United States, but their testimony sometimes can be swayed by their interviewers. Now a new test developed at Cornell University.
New York, NY (February 14, 2003) -- A new laser technology has shown promising early results for the reversal of presbyopia, a progressive stiffening of the eye's lens that occurs with aging and compromises an individual's near vision, or the ability to read without glasses. NewYork-Presbyterian Hospital Weill Cornell Medical Center, first in the New York City-area to offer the new procedure, is currently seeking participants for a Phase II clinical trial of the innovative technology, called OptivisionTM."Everyone over the age of 50 could potentially benefit from this new high-tech treatment," said Dr. Sandra Belmont, Principal Investigator of the new trial and Associate Professor of Clinical Ophthalmology at Weill Cornell Medical College. "The procedure, which takes only thirty minutes per eye, involves eight tiny laser incisions in the sclera, or the white of the eye. This allows the lens to expand, and enables the eye to focus at different distances. Within an hour, patients are able to read without glasses."
A community program to celebrate the life of Dr. Martin Luther King Jr. will be held at the Greater Ithaca Activities Center (GIAC), 318 N. Albany St., on Martin Luther King Day, Monday, Jan. 20, from 11:30 a.m. to 4:30 p.m. The program is free and open to all. This ninth annual event will begin with a luncheon, a keynote speech and performances by local choirs. The keynote speaker this year is Larry Shinagawa, associate professor and director of the Center for the Study of Culture, Race and Ethnicity at Ithaca College. Workshops will follow the luncheon, including children's workshops presented by Cornell University's Herbert F. Johnson Museum of Art and GIAC, storytelling by Jacqueline Scott and a music workshop by Tom Sieling. In addition, there will be a joint Elder-Youth Speakout this year and a workshop by Leslie Schultz and Tammy Baker, titled "Alternatives to Violence." The program will conclude with dessert and additional performances by local choirs. (January 13, 2003)
New York, NY (February 13, 2003)--Our brains are the basis of who we are our intellect, our personality, and our emotional states. At the same time, diseases of the brain rank at the top of the list of our most serious health problems, accounting for more long-term care and chronic suffering than all other medical problems put together. Thus, researchers have long sought to learn more about how the brain works, and how to treat a myriad of brain-related disorders -- from Alzheimer's to Parkinson's, from multiple sclerosis to stroke; from traumatic brain injury to spinal cord injury, and from depression to pain. For the first time, a single, comprehensive home reference, The DANA Guide to Brain Health, is making all of their discoveries accessible to the lay public, along with practical, hands-on advice.
New York, NY (February 13, 2003) -- A team headed by a Weill Cornell Medical College scientist has shown that a virus-inhibiting antibody applied vaginally as a topical microbicide can prevent SHIV infection in a monkey model. A National Institutes of Health (NIH)-funded study provides evidence that microbicides can prevent virus attachment and entry into the vagina and its associated tissues, a useful step in the development of an effective method to prevent the spread of HIV.Published in the March issue of Nature Medicine, the study shows that monkeys treated with a monoclonal antibody microbicide, called b12, were significantly less likely to be infected with SHIV (an engineered simian-human version of human HIV) via the vaginal route than untreated monkeys exposed to the virus (25 percent versus 92 percent). Additionally, a greater dosage of b12, in gel or saline form, resulted in a greater ability to block infection.
Cornell grape breeder Bruce Reisch will officially name and release a new red wine grape during the Viticulture 2003 Conference at the Buffalo Convention Center in Buffalo, NY, on Feb. 20 at 1:30 pm.
